Insider Transactions in Q4 2025 at Keros Therapeutics, Inc. (KROS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2025
|
Orbimed Advisors LLC Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
214,522
-38.94%
|
$3,646,874
$17.75 P/Share
|
|
Nov 21
2025
|
Carl L Gordon Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
214,522
-38.94%
|
$3,646,874
$17.75 P/Share
|
|
Nov 21
2025
|
Julius Knowles |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
322,021
-56.07%
|
$5,474,357
$17.75 P/Share
|
|
Oct 15
2025
|
Pontifax Management 4 G.P. (2015) Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,787,331
-100.0%
|
$81,384,627
$17.75 P/Share
|
|
Oct 15
2025
|
Adar1 Capital Management, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,389,264
-100.0%
|
$91,617,488
$17.75 P/Share
|